How Long Do the Effects of Peyote Last?

Peyote’s psychoactive effects typically last between 10 and 12 hours from the first noticeable changes to the return to baseline, though higher doses can stretch that window to 15 hours or more. The experience usually begins about 30 minutes after ingestion, reaches its peak around 2 hours in, and then gradually tapers over the remaining hours. That makes peyote one of the longest-lasting classical psychedelics, and the timeline is shaped by some unusual pharmacology worth understanding if you want more than a rough estimate.

The General Timeline From Onset to Baseline

After eating peyote cactus or drinking a preparation made from it, the first effects tend to appear within roughly 30 minutes. These early effects are often physical rather than perceptual: nausea is common, along with a sense of bodily heaviness or a shift in temperature perception. Nausea can be significant enough to cause vomiting, which is actually relevant to how long and how intensely the rest of the experience unfolds, since vomiting before full absorption can reduce the effective dose.

The psychedelic peak, where visual changes, emotional intensity, and altered thinking are strongest, arrives around 2 hours after ingestion. One clinical study placed the acute psychotomimetic state, meaning the period of most intense altered consciousness, at roughly 3.5 to 4 hours post-dose.¹ After that, the experience gradually descends through a long plateau phase where effects remain present but less overwhelming, before fading out somewhere around the 10- to 12-hour mark.²

Why Peyote Lasts So Long

Mescaline, the primary psychoactive compound in peyote, is absorbed relatively quickly from the gut, but several things conspire to stretch the experience out. One is simple: mescaline does not cross into the brain very efficiently. It has low lipid solubility, meaning it has a hard time getting past the blood-brain barrier. This is why peyote requires doses in the hundreds of milligrams to produce a full psychedelic experience, whereas something like LSD works at microgram quantities.²

Another factor is that a large fraction of mescaline gets distributed to the liver and kidneys, where it binds to proteins. This essentially creates a reservoir that releases the drug slowly into the bloodstream over hours, delaying and prolonging its concentration in the brain.² Researchers have found higher concentrations of mescaline in the liver and kidneys than in the brain or blood, which fits this picture of the body holding onto the drug in peripheral tissues and releasing it gradually.

There is also an interesting disconnect between when mescaline levels peak in the blood and when subjective effects peak. Blood plasma concentrations top out at around 2 hours, yet the most intense psychological effects arrive somewhat later. This lag suggests that mescaline may undergo some kind of bioactivation, where the body converts it into active forms that take additional time to reach or act on their targets in the brain.² The slow absorption and slow brain entry together account for the long duration: a 2024 controlled study concluded that the relatively long duration of mescaline’s action is “attributable to slow absorption and consequently a long time to reach maximal effects.”³

A Note on Mescaline’s Half-Life

If you look into peyote pharmacology, you will encounter two different numbers for mescaline’s plasma half-life, and the discrepancy is worth flagging. Older literature cites a half-life of about 6 hours.¹ More recent controlled studies using pure mescaline hydrochloride in healthy volunteers have measured a shorter half-life of about 3.5 hours, with dose-proportional kinetics and linear elimination.⁴ The newer figure comes from well-controlled clinical settings with precise dosing and plasma sampling, so it likely reflects the actual elimination of mescaline itself more accurately. The older 6-hour figure may reflect the total pharmacological footprint, including active metabolites or the slow release from organ reservoirs, rather than pure plasma clearance.

Either way, a half-life of 3.5 hours does not mean the trip lasts only 7 hours. Subjective effects outlast what you would predict from plasma levels alone, because of the slow absorption, protein binding in the liver, and the probable role of metabolites. The drug spends a long time getting into the brain and a long time getting out.

How Dose Changes the Duration

The amount of mescaline consumed has a surprisingly dramatic effect on how long the experience lasts. A 2025 pharmacokinetic study tested multiple dose levels from 100 mg up to 800 mg of mescaline hydrochloride and found that the predicted duration of “any drug effect” scaled steeply with dose. At 100 mg, effects lasted roughly 2.8 hours and reached only about 13 percent of maximum possible intensity. At 800 mg, effects stretched to about 15 hours and reached close to 90 percent of maximum intensity.⁴

That is a wide range. The commonly cited 10-to-12-hour figure roughly corresponds to moderate-to-high doses, the kind historically used in ceremonial settings. But a lower dose could be over in a few hours, while a very high dose could persist well into the next morning. Peyote cactus itself adds another wrinkle: the mescaline concentration varies from plant to plant, so the dose you actually consume from raw cactus material is hard to estimate precisely. Two seemingly similar preparations could deliver meaningfully different amounts of mescaline, leading to different durations and intensities.

How Peyote Compares to Other Psychedelics

A randomized clinical trial directly compared mescaline, LSD, and psilocybin in the same participants under controlled conditions. Mescaline came in with the longest average effect duration at about 11 hours, compared to about 8 hours for LSD and about 5 hours for psilocybin.⁵ This head-to-head comparison confirms what decades of anecdotal reports have suggested: peyote is among the longest psychedelic experiences you can have from a single oral dose.

The reason for the difference goes back to mescaline’s weak receptor affinity. Compared to other psychedelic compounds, mescaline binds to serotonin receptors with relatively moderate strength.⁶ To compensate, the body needs a lot more of it to produce a full psychedelic effect, and clearing a larger total mass of drug from the system takes longer. LSD, by contrast, is potent at microgram doses and engages its receptors differently; psilocybin is converted to psilocin, which is broken down faster. The qualitative character of the experience differs between these substances, but the duration difference is the most practically relevant distinction for anyone planning around the commitment a peyote session requires.

What Influences Duration From Person to Person

Individual variation in how long peyote lasts is real, and it is driven by the same pharmacological features that make mescaline unusual. Because so much of the drug gets sequestered in the liver and kidneys rather than immediately circulating to the brain, differences in liver function, body composition, and kidney efficiency can meaningfully shift the timeline. Someone with more efficient hepatic clearance might process the drug somewhat faster; someone with compromised kidney function might eliminate it more slowly.

Stomach contents and nausea also matter. Peyote is notorious for causing vomiting. In controlled studies, researchers found that higher mescaline doses resulted in lower-than-expected plasma concentrations, likely because vomiting expelled some of the drug before it could be absorbed. When the same high dose was co-administered with an anti-nausea agent, the expected plasma concentrations were restored.³ This means that a person who vomits early after eating peyote may have a shorter, weaker experience than one who manages to keep it down. In traditional ceremonial contexts, this variability is well known, and vomiting is sometimes reframed as a spiritual purging rather than a pharmacological inconvenience.

Hydration and food intake before the experience can influence how quickly absorption occurs. An empty stomach generally leads to faster onset, while a full stomach may delay the appearance of effects and potentially alter peak intensity, though this has not been studied in controlled peyote-specific trials.

Drug Interactions That Can Alter the Timeline

Remarkably little clinical research exists on how other drugs interact with mescaline specifically. Most of what we know about psychedelic drug interactions comes from studies of LSD and psilocybin, and the assumption is that similar mechanisms apply since these substances all work primarily through serotonin receptors. A systematic review of psychedelic drug interactions found that lithium, a mood stabilizer, intensified and accelerated the onset of LSD’s effects in the few documented cases.⁷ Whether lithium would have the same effect on mescaline has not been formally tested, but given the shared receptor pharmacology, the concern is warranted enough that researchers and harm-reduction advocates flag it.

SSRIs and other serotonergic medications are another common question. These drugs tend to blunt or reduce the subjective effects of psychedelics in anecdotal reports, and some clinical evidence supports this for LSD and psilocybin. For mescaline specifically, the evidence is thin, but the mechanism is plausible: if serotonin reuptake inhibitors are already occupying or modifying the same receptor sites mescaline needs to act on, the experience could be dampened or shortened. Conversely, MAO inhibitors, which slow the breakdown of many drugs including serotonergic ones, could theoretically prolong or intensify the experience. The controlled mescaline study from 2024 found that co-administration of ketanserin, a serotonin 5-HT2A receptor blocker, significantly reduced mescaline’s subjective effects, confirming that the 5-HT2A receptor is central to the psychedelic action.³

Tolerance With Repeated Use

Like other serotonergic psychedelics, mescaline produces tolerance with repeated dosing. The brain’s response to sustained receptor activation is to downregulate or become less sensitive to the stimulus. In animal studies, repeated mescaline administration led to partial tolerance to the drug’s arousal effects, reflected in a gradual decrease in how long it took animals to return to normal sleep patterns after each dose.⁸ In practical terms, if someone were to use peyote on consecutive days, each successive experience would likely be weaker and potentially shorter for the same dose. Cross-tolerance with other classical psychedelics also exists, meaning that recent use of LSD or psilocybin can blunt the effects of mescaline and vice versa. The typical recommendation in psychedelic circles is to wait at least one to two weeks between sessions for tolerance to fully reset.

What Lingers After the Acute Effects End

The 10-to-12-hour window describes the acute psychedelic experience, but that is not the complete picture. Many people report an “afterglow” period lasting anywhere from a day to several days, characterized by elevated mood, a sense of openness, and subtle perceptual shifts like colors appearing more vivid. This afterglow is not unique to peyote and occurs with most classical psychedelics, but peyote’s longer acute duration seems to correlate with a somewhat extended transition period before a person feels fully back to their ordinary state.

In ceremonial contexts, particularly among members of the Native American Church, participants have described lasting changes that extend far beyond the afterglow. Qualitative research on ceremonial peyote use found that participants reported reduced drug and alcohol misuse, new perspectives on life, improved mental health, and improved physical health. The duration and permanence of these changes varied, with participants attributing them to an improved ability to endure challenges, a sense of neurological “rewiring,” and connection with spiritual experience.⁹ These are self-reported outcomes, not clinical measurements, but they point to effects that the pharmacokinetic timeline does not capture.

How Long Mescaline Stays Detectable in the Body

Even after the subjective effects are over, mescaline and its metabolites continue to clear from the body. About half of an oral dose is excreted unchanged in urine, and roughly a third is excreted as the metabolite 3,4,5-trimethoxyphenylacetic acid (TMPA) over the course of 24 to 30 hours.⁴ Older data suggests that about 87 percent of the TMPA metabolite is excreted within the first 24 hours, with 96 percent cleared within 48 hours.²

Mescaline does not appear on standard drug screening panels. The typical workplace urine drug test checks for amphetamines, opioids, cannabis, cocaine, and PCP. Specialized immunoassay or mass spectrometry testing can detect mescaline, but these are rarely ordered outside of forensic investigations or clinical research. If detection were specifically sought, a urine sample collected within 48 hours of use would have the highest likelihood of returning a positive result based on the elimination data.

Persisting Perceptual Changes

A small percentage of people who use hallucinogens, including mescaline, experience lingering perceptual disturbances well after the drug has left their system. This condition, known as hallucinogen persisting perception disorder (HPPD), involves visual phenomena like halos around lights, trailing images, or geometric patterns that persist or recur weeks or months after use. Estimates suggest that roughly 4 to 4.5 percent of people with a history of hallucinogen use develop HPPD, and the likelihood does not appear to correlate with how much of the drug was consumed.¹⁰ HPPD remains poorly understood, and there is no consensus on what predisposes certain individuals to it. It is uncommon enough that most peyote users will never encounter it, but it represents the far end of the “how long do effects last” question: for a small number of people, some perceptual effects do not fully resolve.

HPPD is distinct from flashbacks, which are brief and spontaneous re-experiences of parts of the psychedelic state. Flashbacks tend to be transient and often decline in frequency over time, while HPPD involves more persistent changes. Both are rare relative to the total number of psychedelic experiences, but they complicate any clean answer to how long peyote’s effects last. For the overwhelming majority of users, the experience ends within 12 to 15 hours and leaves no lasting perceptual disruption beyond the mild afterglow period.

1
PubMed Central. An Overview on the Hallucinogenic Peyote and Its Alkaloid Mescaline: The Importance of Context, Ceremony and Culture
2
PubMed Central. Pharmacokinetic and Pharmacodynamic Aspects of Peyote and Mescaline: Clinical and Forensic Repercussions
3
Translational Psychiatry. Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects
4
PubMed Central. Pharmacokinetics, Pharmacodynamics, and Urinary Recovery of Oral Mescaline Hydrochloride in Healthy Participants
5
PubMed Central. Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
6
bioRxiv. Behavioral pharmacology of mescaline – the role of serotonin 5-HT2A, 5-HT2B, 5-HT2C and 5-HT1A receptors
7
PubMed Central. Drug–drug interactions involving classic psychedelics: A systematic review
8
PubMed. Electroencephalographic studies on the development of tolerance and cross tolerance to mescaline in the rat
9
Journal of Drug Issues. Hitting the Reset Button: Ceremonial Use of Peyote and Experiences of Personal Change
10
PubMed Central. Hallucinogen-Induced Persisting Perception Disorder: A Case Report